Fragment-based Drug Discovery Market, Global Outlook and Forecast 2023-2029

Publisher Name :
Date: 03-Feb-2023
No. of pages: 60

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.

This report aims to provide a comprehensive presentation of the global market for Fragment-based Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fragment-based Drug Discovery. This report contains market size and forecasts of Fragment-based Drug Discovery in global, including the following market information:

Global Fragment-based Drug Discovery Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

The global Fragment-based Drug Discovery market was valued at US$ 342.4 million in 2022 and is projected to reach US$ 522.5 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

Fragment Screening Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Fragment-based Drug Discovery include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fragment-based Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fragment-based Drug Discovery Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Fragment-based Drug Discovery Market Segment Percentages, by Type, 2022 (%)

- Fragment Screening

- Fragment Optimization

Global Fragment-based Drug Discovery Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Fragment-based Drug Discovery Market Segment Percentages, by Application, 2022 (%)

- Academic and Research Institutions

- Biopharmaceutical Companies

- Contract Research Organizations (CROs)

Global Fragment-based Drug Discovery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Fragment-based Drug Discovery Market Segment Percentages, By Region and Country, 2022 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fragment-based Drug Discovery revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies Fragment-based Drug Discovery revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Astex Pharmaceuticals

- Alveus Pharmaceuticals

- Beactica

- Charles River Laboratories

- Crown Bioscience

- Emerald BioStructures

- Evotec

- Kinetic Discovery

- Proteros Fragments

- Sprint Bioscience

- Structure Based Design

- Sygnature Discovery

Outline of Major Chapters:

Chapter 1: Introduces the definition of Fragment-based Drug Discovery, market overview.

Chapter 2: Global Fragment-based Drug Discovery market size in revenue.

Chapter 3: Detailed analysis of Fragment-based Drug Discovery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fragment-based Drug Discovery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Fragment-based Drug Discovery Market, Global Outlook and Forecast 2023-2029

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Fragment-based Drug Discovery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fragment-based Drug Discovery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fragment-based Drug Discovery Overall Market Size
2.1 Global Fragment-based Drug Discovery Market Size: 2022 VS 2029
2.2 Global Fragment-based Drug Discovery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fragment-based Drug Discovery Players in Global Market
3.2 Top Global Fragment-based Drug Discovery Companies Ranked by Revenue
3.3 Global Fragment-based Drug Discovery Revenue by Companies
3.4 Top 3 and Top 5 Fragment-based Drug Discovery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fragment-based Drug Discovery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fragment-based Drug Discovery Players in Global Market
3.6.1 List of Global Tier 1 Fragment-based Drug Discovery Companies
3.6.2 List of Global Tier 2 and Tier 3 Fragment-based Drug Discovery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fragment-based Drug Discovery Market Size Markets, 2022 & 2029
4.1.2 Fragment Screening
4.1.3 Fragment Optimization
4.2 By Type - Global Fragment-based Drug Discovery Revenue & Forecasts
4.2.1 By Type - Global Fragment-based Drug Discovery Revenue, 2018-2023
4.2.2 By Type - Global Fragment-based Drug Discovery Revenue, 2024-2029
4.2.3 By Type - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fragment-based Drug Discovery Market Size, 2022 & 2029
5.1.2 Academic and Research Institutions
5.1.3 Biopharmaceutical Companies
5.1.4 Contract Research Organizations (CROs)
5.2 By Application - Global Fragment-based Drug Discovery Revenue & Forecasts
5.2.1 By Application - Global Fragment-based Drug Discovery Revenue, 2018-2023
5.2.2 By Application - Global Fragment-based Drug Discovery Revenue, 2024-2029
5.2.3 By Application - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Fragment-based Drug Discovery Market Size, 2022 & 2029
6.2 By Region - Global Fragment-based Drug Discovery Revenue & Forecasts
6.2.1 By Region - Global Fragment-based Drug Discovery Revenue, 2018-2023
6.2.2 By Region - Global Fragment-based Drug Discovery Revenue, 2024-2029
6.2.3 By Region - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Fragment-based Drug Discovery Revenue, 2018-2029
6.3.2 US Fragment-based Drug Discovery Market Size, 2018-2029
6.3.3 Canada Fragment-based Drug Discovery Market Size, 2018-2029
6.3.4 Mexico Fragment-based Drug Discovery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Fragment-based Drug Discovery Revenue, 2018-2029
6.4.2 Germany Fragment-based Drug Discovery Market Size, 2018-2029
6.4.3 France Fragment-based Drug Discovery Market Size, 2018-2029
6.4.4 U.K. Fragment-based Drug Discovery Market Size, 2018-2029
6.4.5 Italy Fragment-based Drug Discovery Market Size, 2018-2029
6.4.6 Russia Fragment-based Drug Discovery Market Size, 2018-2029
6.4.7 Nordic Countries Fragment-based Drug Discovery Market Size, 2018-2029
6.4.8 Benelux Fragment-based Drug Discovery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Fragment-based Drug Discovery Revenue, 2018-2029
6.5.2 China Fragment-based Drug Discovery Market Size, 2018-2029
6.5.3 Japan Fragment-based Drug Discovery Market Size, 2018-2029
6.5.4 South Korea Fragment-based Drug Discovery Market Size, 2018-2029
6.5.5 Southeast Asia Fragment-based Drug Discovery Market Size, 2018-2029
6.5.6 India Fragment-based Drug Discovery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Fragment-based Drug Discovery Revenue, 2018-2029
6.6.2 Brazil Fragment-based Drug Discovery Market Size, 2018-2029
6.6.3 Argentina Fragment-based Drug Discovery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fragment-based Drug Discovery Revenue, 2018-2029
6.7.2 Turkey Fragment-based Drug Discovery Market Size, 2018-2029
6.7.3 Israel Fragment-based Drug Discovery Market Size, 2018-2029
6.7.4 Saudi Arabia Fragment-based Drug Discovery Market Size, 2018-2029
6.7.5 UAE Fragment-based Drug Discovery Market Size, 2018-2029
7 Fragment-based Drug Discovery Companies Profiles
7.1 Astex Pharmaceuticals
7.1.1 Astex Pharmaceuticals Company Summary
7.1.2 Astex Pharmaceuticals Business Overview
7.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Major Product Offerings
7.1.4 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.1.5 Astex Pharmaceuticals Key News & Latest Developments
7.2 Alveus Pharmaceuticals
7.2.1 Alveus Pharmaceuticals Company Summary
7.2.2 Alveus Pharmaceuticals Business Overview
7.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Major Product Offerings
7.2.4 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.2.5 Alveus Pharmaceuticals Key News & Latest Developments
7.3 Beactica
7.3.1 Beactica Company Summary
7.3.2 Beactica Business Overview
7.3.3 Beactica Fragment-based Drug Discovery Major Product Offerings
7.3.4 Beactica Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.3.5 Beactica Key News & Latest Developments
7.4 Charles River Laboratories
7.4.1 Charles River Laboratories Company Summary
7.4.2 Charles River Laboratories Business Overview
7.4.3 Charles River Laboratories Fragment-based Drug Discovery Major Product Offerings
7.4.4 Charles River Laboratories Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.4.5 Charles River Laboratories Key News & Latest Developments
7.5 Crown Bioscience
7.5.1 Crown Bioscience Company Summary
7.5.2 Crown Bioscience Business Overview
7.5.3 Crown Bioscience Fragment-based Drug Discovery Major Product Offerings
7.5.4 Crown Bioscience Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.5.5 Crown Bioscience Key News & Latest Developments
7.6 Emerald BioStructures
7.6.1 Emerald BioStructures Company Summary
7.6.2 Emerald BioStructures Business Overview
7.6.3 Emerald BioStructures Fragment-based Drug Discovery Major Product Offerings
7.6.4 Emerald BioStructures Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.6.5 Emerald BioStructures Key News & Latest Developments
7.7 Evotec
7.7.1 Evotec Company Summary
7.7.2 Evotec Business Overview
7.7.3 Evotec Fragment-based Drug Discovery Major Product Offerings
7.7.4 Evotec Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.7.5 Evotec Key News & Latest Developments
7.8 Kinetic Discovery
7.8.1 Kinetic Discovery Company Summary
7.8.2 Kinetic Discovery Business Overview
7.8.3 Kinetic Discovery Fragment-based Drug Discovery Major Product Offerings
7.8.4 Kinetic Discovery Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.8.5 Kinetic Discovery Key News & Latest Developments
7.9 Proteros Fragments
7.9.1 Proteros Fragments Company Summary
7.9.2 Proteros Fragments Business Overview
7.9.3 Proteros Fragments Fragment-based Drug Discovery Major Product Offerings
7.9.4 Proteros Fragments Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.9.5 Proteros Fragments Key News & Latest Developments
7.10 Sprint Bioscience
7.10.1 Sprint Bioscience Company Summary
7.10.2 Sprint Bioscience Business Overview
7.10.3 Sprint Bioscience Fragment-based Drug Discovery Major Product Offerings
7.10.4 Sprint Bioscience Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.10.5 Sprint Bioscience Key News & Latest Developments
7.11 Structure Based Design
7.11.1 Structure Based Design Company Summary
7.11.2 Structure Based Design Business Overview
7.11.3 Structure Based Design Fragment-based Drug Discovery Major Product Offerings
7.11.4 Structure Based Design Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.11.5 Structure Based Design Key News & Latest Developments
7.12 Sygnature Discovery
7.12.1 Sygnature Discovery Company Summary
7.12.2 Sygnature Discovery Business Overview
7.12.3 Sygnature Discovery Fragment-based Drug Discovery Major Product Offerings
7.12.4 Sygnature Discovery Fragment-based Drug Discovery Revenue in Global Market (2018-2023)
7.12.5 Sygnature Discovery Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Fragment-based Drug Discovery Market Opportunities & Trends in Global Market
Table 2. Fragment-based Drug Discovery Market Drivers in Global Market
Table 3. Fragment-based Drug Discovery Market Restraints in Global Market
Table 4. Key Players of Fragment-based Drug Discovery in Global Market
Table 5. Top Fragment-based Drug Discovery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Fragment-based Drug Discovery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Fragment-based Drug Discovery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Fragment-based Drug Discovery Product Type
Table 9. List of Global Tier 1 Fragment-based Drug Discovery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fragment-based Drug Discovery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Fragment-based Drug Discovery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Fragment-based Drug Discovery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Fragment-based Drug Discovery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Fragment-based Drug Discovery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Fragment-based Drug Discovery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Fragment-based Drug Discovery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Fragment-based Drug Discovery Revenue, (US$, Mn), 2024-2029
Table 30. Astex Pharmaceuticals Company Summary
Table 31. Astex Pharmaceuticals Fragment-based Drug Discovery Product Offerings
Table 32. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 33. Astex Pharmaceuticals Key News & Latest Developments
Table 34. Alveus Pharmaceuticals Company Summary
Table 35. Alveus Pharmaceuticals Fragment-based Drug Discovery Product Offerings
Table 36. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 37. Alveus Pharmaceuticals Key News & Latest Developments
Table 38. Beactica Company Summary
Table 39. Beactica Fragment-based Drug Discovery Product Offerings
Table 40. Beactica Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 41. Beactica Key News & Latest Developments
Table 42. Charles River Laboratories Company Summary
Table 43. Charles River Laboratories Fragment-based Drug Discovery Product Offerings
Table 44. Charles River Laboratories Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 45. Charles River Laboratories Key News & Latest Developments
Table 46. Crown Bioscience Company Summary
Table 47. Crown Bioscience Fragment-based Drug Discovery Product Offerings
Table 48. Crown Bioscience Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 49. Crown Bioscience Key News & Latest Developments
Table 50. Emerald BioStructures Company Summary
Table 51. Emerald BioStructures Fragment-based Drug Discovery Product Offerings
Table 52. Emerald BioStructures Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 53. Emerald BioStructures Key News & Latest Developments
Table 54. Evotec Company Summary
Table 55. Evotec Fragment-based Drug Discovery Product Offerings
Table 56. Evotec Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 57. Evotec Key News & Latest Developments
Table 58. Kinetic Discovery Company Summary
Table 59. Kinetic Discovery Fragment-based Drug Discovery Product Offerings
Table 60. Kinetic Discovery Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 61. Kinetic Discovery Key News & Latest Developments
Table 62. Proteros Fragments Company Summary
Table 63. Proteros Fragments Fragment-based Drug Discovery Product Offerings
Table 64. Proteros Fragments Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 65. Proteros Fragments Key News & Latest Developments
Table 66. Sprint Bioscience Company Summary
Table 67. Sprint Bioscience Fragment-based Drug Discovery Product Offerings
Table 68. Sprint Bioscience Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 69. Sprint Bioscience Key News & Latest Developments
Table 70. Structure Based Design Company Summary
Table 71. Structure Based Design Fragment-based Drug Discovery Product Offerings
Table 72. Structure Based Design Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 73. Structure Based Design Key News & Latest Developments
Table 74. Sygnature Discovery Company Summary
Table 75. Sygnature Discovery Fragment-based Drug Discovery Product Offerings
Table 76. Sygnature Discovery Fragment-based Drug Discovery Revenue (US$, Mn) & (2018-2023)
Table 77. Sygnature Discovery Key News & Latest Developments
List of Figures
Figure 1. Fragment-based Drug Discovery Segment by Type in 2022
Figure 2. Fragment-based Drug Discovery Segment by Application in 2022
Figure 3. Global Fragment-based Drug Discovery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fragment-based Drug Discovery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fragment-based Drug Discovery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2022
Figure 8. By Type - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 16. US Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 20. Germany Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 21. France Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 28. China Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 32. India Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 34. Brazil Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Fragment-based Drug Discovery Revenue Market Share, 2018-2029
Figure 37. Turkey Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Fragment-based Drug Discovery Revenue, (US$, Mn), 2018-2029
Figure 41. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Beactica Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Charles River Laboratories Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Crown Bioscience Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Emerald BioStructures Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Evotec Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kinetic Discovery Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Proteros Fragments Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sprint Bioscience Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Structure Based Design Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sygnature Discovery Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs